Ribomic Inc
TSE:4591

Watchlist Manager
Ribomic Inc Logo
Ribomic Inc
TSE:4591
Watchlist
Price: 81 JPY Market Closed
Market Cap: 3.3B JPY
Have any thoughts about
Ribomic Inc?
Write Note

Intrinsic Value

The intrinsic value of one Ribomic Inc stock under the Base Case scenario is 35.01 JPY. Compared to the current market price of 81 JPY, Ribomic Inc is Overvalued by 57%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
35.01 JPY
Overvaluation 57%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Ribomic Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Ribomic Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Ribomic Inc?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Biotechnology Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Ribomic Inc

Provide an overview of the primary business activities
of Ribomic Inc.

What unique competitive advantages
does Ribomic Inc hold over its rivals?

What risks and challenges
does Ribomic Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ribomic Inc.

Provide P/S
for Ribomic Inc.

Provide P/E
for Ribomic Inc.

Provide P/OCF
for Ribomic Inc.

Provide P/FCFE
for Ribomic Inc.

Provide P/B
for Ribomic Inc.

Provide EV/S
for Ribomic Inc.

Provide EV/GP
for Ribomic Inc.

Provide EV/EBITDA
for Ribomic Inc.

Provide EV/EBIT
for Ribomic Inc.

Provide EV/OCF
for Ribomic Inc.

Provide EV/FCFF
for Ribomic Inc.

Provide EV/IC
for Ribomic Inc.

What are the Revenue projections
for Ribomic Inc?

How accurate were the past Revenue estimates
for Ribomic Inc?

What are the Net Income projections
for Ribomic Inc?

How accurate were the past Net Income estimates
for Ribomic Inc?

What are the EPS projections
for Ribomic Inc?

How accurate were the past EPS estimates
for Ribomic Inc?

What are the EBIT projections
for Ribomic Inc?

How accurate were the past EBIT estimates
for Ribomic Inc?

Compare the revenue forecasts
for Ribomic Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ribomic Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ribomic Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ribomic Inc compared to its peers.

Compare the P/E ratios
of Ribomic Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Ribomic Inc with its peers.

Analyze the financial leverage
of Ribomic Inc compared to its main competitors.

Show all profitability ratios
for Ribomic Inc.

Provide ROE
for Ribomic Inc.

Provide ROA
for Ribomic Inc.

Provide ROIC
for Ribomic Inc.

Provide ROCE
for Ribomic Inc.

Provide Gross Margin
for Ribomic Inc.

Provide Operating Margin
for Ribomic Inc.

Provide Net Margin
for Ribomic Inc.

Provide FCF Margin
for Ribomic Inc.

Show all solvency ratios
for Ribomic Inc.

Provide D/E Ratio
for Ribomic Inc.

Provide D/A Ratio
for Ribomic Inc.

Provide Interest Coverage Ratio
for Ribomic Inc.

Provide Altman Z-Score Ratio
for Ribomic Inc.

Provide Quick Ratio
for Ribomic Inc.

Provide Current Ratio
for Ribomic Inc.

Provide Cash Ratio
for Ribomic Inc.

What is the historical Revenue growth
over the last 5 years for Ribomic Inc?

What is the historical Net Income growth
over the last 5 years for Ribomic Inc?

What is the current Free Cash Flow
of Ribomic Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ribomic Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ribomic Inc

Current Assets 3.3B
Cash & Short-Term Investments 3.1B
Receivables 80.1m
Other Current Assets 56.9m
Non-Current Assets 40.4m
PP&E 375k
Other Non-Current Assets 40m
Current Liabilities 152.4m
Accrued Liabilities 15.4m
Other Current Liabilities 137m
Efficiency

Earnings Waterfall
Ribomic Inc

Revenue
1.5m JPY
Operating Expenses
-1.1B JPY
Operating Income
-1.1B JPY
Other Expenses
131.6m JPY
Net Income
-944m JPY

Free Cash Flow Analysis
Ribomic Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Ribomic Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

12/100
Profitability
Score

Ribomic Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Ribomic Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Ribomic Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Ribomic Inc

There are no price targets for Ribomic Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Ribomic Inc?

Click here to dive deeper.

Dividends

Ribomic Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for Ribomic Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Ribomic Inc Logo
Ribomic Inc

Country

Japan

Industry

Biotechnology

Market Cap

3.3B JPY

Dividend Yield

0%

Description

RIBOMIC, Inc. engages in the research and development of molecular targeted drugs using Ribonucleic Acid (RNA) aptamers for use in therapeutic fields. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 25 full-time employees. The company went IPO on 2014-09-25. Its drug discovery business is divided into self discovery and co-discovery divisions. Self Drug Discovery division develops aptamer and licenses and out the results to pharmaceutical companies. The Co-Discovery division earns the research expenses paid by the alliance partner for the shared part of co-discovery business with alliance pharmaceutical companies researching aptamer pharmaceutical.

Contact

TOKYO-TO
Minato-ku
6F, Shirokanedai Usui Bldg., 3-16-13, Shirokanedai
+81334403303.0
www.ribomic.com

IPO

2014-09-25

Employees

25

Officers

CEO, President & Representative Director
Mr. Yoshikazu Nakamura Ph.D.
Executive Officer, GM of Business Administration Department
Mr. Masayuki Miyazaki
Executive Officer, GM of Management Headquarters & Director
Hisato Oiwa

See Also

Discover More
What is the Intrinsic Value of one Ribomic Inc stock?

The intrinsic value of one Ribomic Inc stock under the Base Case scenario is 35.01 JPY.

Is Ribomic Inc stock undervalued or overvalued?

Compared to the current market price of 81 JPY, Ribomic Inc is Overvalued by 57%.

Back to Top